news
Bryostatin-1 shows early promise for dormant HIV infection
Scientists have designed a synthetic molecule bryostatin-1 that can reactivate dormant HIV...
List view / Grid view
UCLA
news
Gene therapy may lower risk for heart disease
Researchers have tested whether a single injection of the gene, LeXis could slow down the development of heart disease...
news
Balance and movement improved in animal model of Parkinson’s disease
Researchers have developed a molecular compound that improves balance and coordination in mice with early stage Parkinson's disease.
article
Predictions for the future: How nanoscience will improve our health and lives
27 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers at UCLA discuss the growing trend of nanoscience, making their scientific predictions for the future of this tech and its global impact...
news
A protective strategy against pesticide-linked Parkinson’s disease
15 June 2016 | By Victoria White, Digital Content Producer
UCLA researchers have found that elimination of the α-synuclein protein protected zebrafish against ziram-induced loss of dopamine neurons...
news
Biomarkers that could give better cancer survival estimates
9 June 2016 | By Victoria White, Digital Content Producer
A new method, developed by UCLA scientists, could eventually lead to a way to improve accuracy of how well a patient will respond to treatment...
news
The genetic evolution of the Zika virus
15 April 2016 | By Victoria White, Digital Content Producer
An analysis comparing the differences between over 40 strains of Zika virus identified significant changes in both amino acid and nucleotide sequences...
news
Researchers identify promising drug combination for tuberculosis
29 March 2016 | By Victoria White
Researchers used feedback system control to quickly narrow combinations of 14 different tuberculosis drugs with five different doses into several promising combination treatments...
news
BMS and UCLA team up for immuno-oncology collaboration
14 December 2015 | By Victoria White
Bristol-Myers Squibb and the David Geffen School of Medicine at UCLA will conduct a range of early phase clinical studies as part of the I-O RPM research programme...
news
UCLA researchers identify drug that helps fight side effect of ovarian cancer
17 November 2015 | By Victoria White
The researchers found that a drug that inhibits a receptor called the Colony-Stimulating-Factor-1 Receptor reduces ascites with minimal side effects...
news
UCLA discovery could lead to better recovery after stroke
28 October 2015 | By Victoria White
Researchers have identified a molecule that, after a stroke, initiate repairs to the brain...
news
UCLA scientists discover therapy that can suppress ulcerative colitis
24 July 2015 | By Victoria White
UCLA scientists have discovered a microRNA-214 inhibitor that has the ability to suppress the development of ulcerative colitis...